Professional Documents
Culture Documents
CAS-No. 68-12-2
1.2 Relevant identified uses of the substance or mixture and uses advised against
Identified uses Reagent for analysis, Chemical production
In compliance with the conditions described in the annex to
this safety data sheet.
Page 1 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Hazard pictograms
Signal word
Danger
Hazard statements
H360D May damage the unborn child.
H226 Flammable liquid and vapour.
H312 + H332 Harmful in contact with skin or if inhaled.
H319 Causes serious eye irritation.
Precautionary statements
Prevention
P201 Obtain special instructions before use.
P210 Keep away from heat.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue rinsing.
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Signal word
Danger
Hazard statements
H360D May damage the unborn child.
Precautionary statements
P201 Obtain special instructions before use.
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Index-No. 616-001-00-X
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
68-12-2 01-2119475605-
32-XXXX Flammable liquid, Category 3, H226
Acute toxicity, Category 4, H332
Acute toxicity, Category 4, H312
Eye irritation, Category 2, H319
Reproductive toxicity, Category 1B, H360D
For the full text of the H-Statements mentioned in this Section, see Section 16.
3.2 Mixture
Not applicable
4.2 Most important symptoms and effects, both acute and delayed
Gastrointestinal disturbance, Vomiting, Nausea, Headache, Dizziness, Drowsiness
irritant effects
4.3 Indication of any immediate medical attention and special treatment needed
No information available.
Page 3 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Page 4 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Engineering measures
Page 5 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Page 6 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Form liquid
Colour colourless
Odour amine-like
pH 7
at 200 g/l
20 °C
Page 7 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Page 8 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
(IUCLID)
Eye irritation
Rabbit
Result: Eye irritation
(IUCLID)
Causes serious eye irritation.
Sensitisation
Sensitisation test: Guinea pig
Result: negative
(Lit.)
Sensitisation test: Mouse
Result: negative
Method: OECD Test Guideline 406
(ECHA)
Page 9 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Genotoxicity in vitro
Ames test
Salmonella typhimurium
Result: negative
(ECHA)
Carcinogenicity
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
(Lit.)
Theoretical oxygen demand (ThOD)
1.863 mg/g
(Lit.)
12.3 Bioaccumulative potential
Partition coefficient: n-octanol/water
log Pow: -0,85 (25 °C)
OECD Test Guideline 107
Page 11 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Page 12 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
14.7 Transport in bulk according to Annex II of MARPOL 73/78 and the IBC
Code
Not relevant
Substances of very high concern (SVHC) This product does contain substances
of very high concern according to
Regulation (EC) No 1907/2006
(REACH), Article 59 above the
respective regulatory concentration
limit of > 0.1 % (w/w).
Contains: N,N-dimethylformamide
National legislation
Storage class 3
Page 13 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Training advice
Provide adequate information, instruction and training for operators.
Labelling
Hazard pictograms
Signal word
Danger
Hazard statements
H226 Flammable liquid and vapour.
H312 + H332 Harmful in contact with skin or if inhaled.
H319 Causes serious eye irritation.
H360 May damage fertility or the unborn child.
Precautionary statements
Prevention
P201 Obtain special instructions before use.
P210 Keep away from heat.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue rinsing.
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Further information
Key or legend to abbreviations and acronyms used in the safety data sheet
Used abbreviations and acronyms can be looked up at www.wikipedia.org.
Regional representation
Page 14 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
This information is given on the authorised Safety Data Sheet for your country.
The information contained herein is based on the present state of our knowledge. It characterises the
product with regard to the appropriate safety precautions. It does not represent a guarantee of any
properties of the product.
Page 15 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Sectors of end-use
SU 3 Industrial uses: Uses of substances as such or in preparations at industrial
sites
SU9 Manufacture of fine chemicals
SU 10 Formulation [mixing] of preparations and/ or re-packaging (excluding alloys)
Chemical product category
PC19 Intermediate
PC21 Laboratory chemicals
Process categories
PROC1 Use in closed process, no likelihood of exposure
PROC2 Use in closed, continuous process with occasional controlled exposure
PROC3 Use in closed batch process (synthesis or formulation)
PROC4 Use in batch and other process (synthesis) where opportunity for exposure
arises
PROC5 Mixing or blending in batch processes for formulation of preparations and
articles (multistage and/ or significant contact)
PROC8a Transfer of substance or preparation (charging/ discharging) from/ to vessels/
large containers at non-dedicated facilities
PROC8b Transfer of substance or preparation (charging/ discharging) from/ to vessels/
large containers at dedicated facilities
PROC9 Transfer of substance or preparation into small containers (dedicated filling line,
including weighing)
PROC15 Use as laboratory reagent
Environmental Release Categories
ERC1 Manufacture of substances
ERC2 Formulation of preparations
ERC4 Industrial use of processing aids in processes and products, not becoming part
of articles
ERC6a Industrial use resulting in manufacture of another substance (use of
intermediates)
ERC6b Industrial use of reactive processing aids
Product characteristics
Concentration of the Covers the percentage of the substance in the product
Substance in Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) Medium volatile liquid
Process Temperature < 84 °C
Page 16 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Additional good practice advice beyond the REACH Chemical Safety Assessment
Additional good practice Wear chemically resistant gloves (tested to EN374) in
advice combination with ‘basic’ employee training.
2.2 Contributing scenario controlling worker exposure for: PROC2, PROC3, PROC4,
PROC8b, PROC15
Product characteristics
Concentration of the Covers the percentage of the substance in the product
Substance in Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) Medium volatile liquid
Process Temperature < 84 °C
Additional good practice advice beyond the REACH Chemical Safety Assessment
Additional good practice Wear chemically resistant gloves (tested to EN374) in
advice combination with ‘basic’ employee training.
2.3 Contributing scenario controlling worker exposure for: PROC5, PROC8a, PROC9
Product characteristics
Concentration of the Covers the percentage of the substance in the product
Substance in Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) Medium volatile liquid
Process Temperature < 84 °C
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Conditions and measures related to personal protection, hygiene and health evaluation
Wear chemically resistant gloves (tested to EN374) in combination with ‘basic’ employee
training.
Workers
Exposure duration, route, Exposure Assessment
CS Use descriptor effect RCR Method
2.1 PROC1 longterm, inhalative, systemic < 0,01 ECETOC TRA 3
longterm, dermal, systemic 0,01 ECETOC TRA 3
longterm, combined, systemic 0,01
2.2 PROC2 longterm, inhalative, systemic 0,10 ECETOC TRA 3
longterm, dermal, systemic 0,04 ECETOC TRA 3
longterm, combined, systemic 0,14
2.2 PROC3 longterm, inhalative, systemic 0,20 ECETOC TRA 3
longterm, dermal, systemic 0,02 ECETOC TRA 3
longterm, combined, systemic 0,22
2.2 PROC4 longterm, inhalative, systemic 0,41 ECETOC TRA 3
longterm, dermal, systemic 0,21 ECETOC TRA 3
longterm, combined, systemic 0,61
2.2 PROC8b longterm, inhalative, systemic 0,25 ECETOC TRA 3
longterm, dermal, systemic 0,21 ECETOC TRA 3
longterm, combined, systemic 0,46
2.2 PROC15 longterm, inhalative, systemic 0,20 ECETOC TRA 3
longterm, dermal, systemic 0,01 ECETOC TRA 3
longterm, combined, systemic 0,21
2.3 PROC5 longterm, inhalative, systemic 0,71 ECETOC TRA 3
longterm, dermal, systemic 0,04 ECETOC TRA 3
longterm, combined, systemic 0,75
2.3 PROC8a longterm, inhalative, systemic 0,71 ECETOC TRA 3
longterm, dermal, systemic 0,04 ECETOC TRA 3
longterm, combined, systemic 0,75
2.3 PROC9 longterm, inhalative, systemic 0,71 ECETOC TRA 3
longterm, dermal, systemic 0,02 ECETOC TRA 3
longterm, combined, systemic 0,73
The default parameters and -efficiencies of the applied exposure assessment model were
used for the calculation (unless stated differently).
Reduction factor for local exhaust ventilation (LEV) has been used for the calculation of
dermal exposure estimates.
Page 18 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
4. Guidance to Downstream User to evaluate whether he works inside the boundaries set
by the Exposure Scenario
For scaling of worker exposure assessments performed with ECETOC TRA, please consult
the Merck tool ScIDeEx® at www.merckmillipore.com/scideex.
Page 19 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Sectors of end-use
SU 22 Professional uses: Public domain (administration, education, entertainment,
services, craftsmen)
Chemical product category
PC21 Laboratory chemicals
Process categories
PROC15 Use as laboratory reagent
Environmental Release Categories
ERC2 Formulation of preparations
ERC6a Industrial use resulting in manufacture of another substance (use of
intermediates)
ERC6b Industrial use of reactive processing aids
Product characteristics
Concentration of the Covers the percentage of the substance in the product
Substance in Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) Medium volatile liquid
Process Temperature < 84 °C
Additional good practice advice beyond the REACH Chemical Safety Assessment
Additional good practice Wear chemically resistant gloves (tested to EN374) in
advice combination with ‘basic’ employee training.
Page 20 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Workers
Exposure duration, route, Exposure Assessment
CS Use descriptor effect RCR Method
2.1 PROC15 longterm, inhalative, systemic 0,41 ECETOC TRA 3
longterm, dermal, systemic 0,02 ECETOC TRA 3
longterm, combined, systemic 0,43
The default parameters and -efficiencies of the applied exposure assessment model were
used for the calculation (unless stated differently).
Reduction factor for local exhaust ventilation (LEV) has been used for the calculation of
dermal exposure estimates.
4. Guidance to Downstream User to evaluate whether he works inside the boundaries set
by the Exposure Scenario
For scaling of worker exposure assessments performed with ECETOC TRA, please consult
the Merck tool ScIDeEx® at www.merckmillipore.com/scideex.
The branding on the header and/or footer of this document may temporarily not visually
match the product purchased as we transition our branding. However, all of the
information in the document regarding the product remains unchanged and matches the
product ordered. For further information please contact mlsbranding@sial.com.
Page 21 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada